Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.93
-0.27 (-3.29%)
Mar 5, 2026, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Fennec Pharmaceuticals stock have an average target of 15, with a low estimate of 13 and a high estimate of 18. The average target predicts an increase of 89.16% from the current stock price of 7.93.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 9, 2026.
Analyst Ratings
The average analyst rating for Fennec Pharmaceuticals stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $18 | Buy | Initiates | $18 | +126.99% | Jan 9, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +63.93% | Aug 21, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +76.54% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +63.93% | May 20, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +63.93% | May 14, 2025 |
Financial Forecast
Revenue This Year
45.96M
from 47.54M
Decreased by -3.33%
Revenue Next Year
78.49M
from 45.96M
Increased by 70.78%
EPS This Year
-0.13
from -0.02
EPS Next Year
0.67
from -0.13
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 49.0M | 91.3M | ||||
| Avg | 46.0M | 78.5M | ||||
| Low | 41.7M | 59.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.1% | 98.7% | ||||
| Avg | -3.3% | 70.8% | ||||
| Low | -12.3% | 29.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.07 | 1.04 | |||
| Avg | -0.13 | 0.67 | |||
| Low | -0.19 | 0.37 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.